The evolution of treatment, complex global stakeholders, and local market paradigms all play a part in how a product is perceived by prescribers and payers/reimbursement bodies. Companies need to plan early in development to generate sufficient evidence to support a product’s value proposition. But even under ideal conditions, with breakthrough science and persuasive data, teams struggle to communicate the innovative advantages, the evidence base for and the additional value of their products.

This session offers an exploration of the steps that can be taken to develop and communicate a compelling, evidence-based value story.
 

During this webinar we will cover:

  • An overview of payer negotiation pitfalls and roadblocks
  • Advice on approaches to developing your value dossier and economic modelling approach
  • Communicating effectively with HTA bodies and payers

 

Click here to register your attendance

Webinar Hosts

Dr Steffen Thirstrup

Advisory Board Director

Read more

 

Professor Carole Longson

Advisory Board Member

Read more

Stay up to date

Contact us

Your drug development needs are unique

Contact us to learn how our experts can support you to meet all regulatory, quality and safety requirements and ensure the best path to approval.

Let's Bring Medicines to the World